MR Imaging of Cerebral Cortical Involvement in Aceruloplasminemia

References

1. ↵
   Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N. Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 1987;37:761–777

   Abstract/FREE Full Text
2. ↵
   Harris LZ, Klomp WJ, Gitlin JD. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis. Am J Clin Nutr 1998;67:972–977
3. ↵
   Kawanami T, Kato T, Daimon M, et al. Hereditary caeruloplasmin deficiency: clinicopathological study of a patient. J Neurol Neurosurg Psychiatry 1996;61:506–509

   Abstract/FREE Full Text
4. ↵
   Kohno S, Miyajima H, Takahashi Y, Suzuki H, Hishida A. Defective electron transfer in complexes I and IV in patients with aceruloplasminemia. J Neurol Sci 2000;182:57–60

   CrossRefPubMed
5. ↵
   Klomp LWJ, Gitlin JD. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenetic model in aceruloplasminemia. Hum Mol Genet 1996;5:1989–1996

   Abstract/FREE Full Text
6. ↵
   Morita H, Ikeda S, Yamamoto K, et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family. Ann Neurol 1995;37:646–656

   CrossRefPubMedWeb of Science
7. Okamoto N, Wada S, Oga T, et al. Hereditary ceruloplasmin deficiency with hemosiderosis. Hum Genet 1996;97:755–758

   CrossRefPubMedWeb of Science
8. Miyajima H, Takahashi Y, Kamata T, Shimizu H, Sakai N, Gitlin JD. Use of desferrioxamine in the treatment of aceruloplasminemia. Ann Neurol 1997;41:404–407

   CrossRefPubMedWeb of Science
9. Miyajima H, Fujimoto M, Kohno S, Kaneko E, Gitlin JD. CSF abnormalities in patients with aceruloplasminemia. Neurology 1998;51:1188–1190

   Abstract/FREE Full Text
10. Servan J, Elghozi D, Gaynot S, Duclos H. Hémosidérose cérébrale liée à un déficit héréditaire en céruloplasmine. Rev Neurol 1998;154:158–162

    PubMed
11. Daimon M, Moriai S, Susa S, Yamatani K, Hosoya T, Kato T. Hypocaeruloplasminaemia with heteroallelic caeruloplasmin gene mutation: MRI of the brain. Neuroradiology 1999;41:185–187

    CrossRefPubMed
12. Loréal O, Turlin B, Pigeon C, et al. Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights. J Hepatol 2002;36:851–856

    CrossRefPubMedWeb of Science
13. ↵
    Miyajima H, Kono S, Takahashi Y, Sugimoto M, Sakamoto M, Sakai N. Cerebellar ataxia associated with heteroallelic ceruloplasmin gene mutation. Neurology 2001;57:2205–2210

    Abstract/FREE Full Text
14. ↵
    Gitlin JD. Aceruloplasminemia. Pediatr Res 1998;44:271–276

    CrossRefPubMedWeb of Science
15. ↵
    Bracchi M, Savoiardo M, Triulzi F, et al. Superficial siderosis of the CNS: MR diagnosis and clinical findings. AJNR Am J Neuroradiol 1993;14:227–236

    Abstract/FREE Full Text
16. ↵
    Sethi KD, Adams RJ, Loring DW, el Gammal T. Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations. Ann Neurol 1988;24:692–694

    CrossRefPubMedWeb of Science
17. ↵
    Savoiardo M, Halliday WC, Nardocci N, et al. Hallervorden-Spatz disease: MR and pathologic findings. AJNR Am J Neuroradiol 1993;14:155–162

    Abstract/FREE Full Text
18. ↵
    Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003;348:33–40

    CrossRefPubMedWeb of Science
19. ↵
    Savoiardo M, Girotti F, Strada L, Ciceri E. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm 1994;42:93–110
20. ↵
    Horimoto Y, Aiba I, Yasuda T, et al. Longitudinal MRI study of multiple system atrophy: when do the findings appear, or what is the course? J Neurol 2002;249:847–854

    CrossRefPubMedWeb of Science
21. ↵
    Nielsen JE, Neerup Jensen L, Krabbe K. Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome. J Neurol Neurosurg Psychiatry 1995;59:318–321

    Abstract/FREE Full Text
22. ↵
    Duprez T, Maiter D, Cosnard G. Transfusional hemochromatosis of the choroid plexus in β-thalassemia major. J Comput Assist Tomogr 2001;25:487–488

    PubMed
23. ↵
    Sparacia G, Banco A, Midiri M, Iaia A. MR imaging technique for the diagnosis of pituitary iron overload in patients with transfusion-dependent β-thalassemia major. AJNR Am J Neuroradiol 1998;19:1905–1907

    Abstract
24. ↵
    Megalhaes ACA, Caramelli P, Menezes JR, et al. Wilson’s disease: MRI with clinical correlation. Neuroradiology 1994;36:97–100

    CrossRefPubMed
25. ↵
    Savoiardo M, Grisoli M. Magnetic resonance imaging of movement disorders. In: Jankovic J, Tolosa E, eds. Parkinson’s Disease and Movement Disorders. 3rd ed. Baltimore: Lippincott Williams & Wilkins,1998;967–990
26. ↵
    Engelbrecht V, Schlaug G, Hefter H, et al. MRI of the brain in Wilson disease: T2 signal loss under therapy. J Comput Assist Tomogr 1995;19:635–638

    PubMed
27. ↵
    van Wassenaer-van Hall HN, van den Heuvel AG, Algra A, et al. Wilson disease: findings at MR imaging and CT of the brain with clinical correlation. Radiology 1996;198:531–536

    PubMedWeb of Science
28. ↵
    van Wassenaer-van Hall HN, van den Heuvel AG, Jansen GH, et al. Cranial MR in Wilson disease: abnormal white matter in extrapyramidal and pyramidal tracts. AJNR Am J Neuroradiol 1995;16:2021–2027

    Abstract